PRKN and ovarian cancer: More than 200 PARK2 gene mutations have been identified, and they contribute to Parkinson's disease and several forms of human cancer, including glioblastoma, colorectal cancer, lung cancer, ovarian cancer, breast cancer, renal cancer, and sporadic colorectal cancer.